Literature DB >> 28865514

Mechanisms of Normal Tissue Injury From Irradiation.

Deborah E Citrin1, James B Mitchell2.   

Abstract

Normal tissue injury from irradiation is an unfortunate consequence of radiotherapy. Technologic improvements have reduced the risk of normal tissue injury; however, toxicity causing treatment breaks or long-term side effects continues to occur in a subset of patients. The molecular events that lead to normal tissue injury are complex and span a variety of biologic processes, including oxidative stress, inflammation, depletion of injured cells, senescence, and elaboration of proinflammatory and profibrogenic cytokines. This article describes selected recent advances in normal tissue radiobiology. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28865514      PMCID: PMC5653270          DOI: 10.1016/j.semradonc.2017.04.001

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  108 in total

1.  Increased expression of nuclear factor E2 p45-related factor 2 (NRF2) in head and neck squamous cell carcinomas.

Authors:  Donnie R Stacy; Kim Ely; Pierre P Massion; Wendell G Yarbrough; Dennis E Hallahan; Konjeti R Sekhar; Michael L Freeman
Journal:  Head Neck       Date:  2006-09       Impact factor: 3.147

2.  Genistein can mitigate the effect of radiation on rat lung tissue.

Authors:  Victoria L Calveley; Salomeh Jelveh; Aimee Langan; Javed Mahmood; Ivan W T Yeung; Jake Van Dyk; Richard P Hill
Journal:  Radiat Res       Date:  2010-05       Impact factor: 2.841

Review 3.  IL-17 and neutrophils: unexpected players in the type 2 immune response.

Authors:  Judith E Allen; Tara E Sutherland; Dominik Rückerl
Journal:  Curr Opin Immunol       Date:  2015-03-18       Impact factor: 7.486

4.  Interleukin-17A antagonist attenuates radiation-induced lung injuries in mice.

Authors:  Bao-Zhong Wang; Li-Ping Wang; Hui Han; Fang-Li Cao; Guang-Yao Li; Jun-Long Xu; Xiu-Wen Wang; Le-Xin Wang
Journal:  Exp Lung Res       Date:  2014-01-21       Impact factor: 2.459

5.  Characterization of transgenic Gfrp knock-in mice: implications for tetrahydrobiopterin in modulation of normal tissue radiation responses.

Authors:  Rupak Pathak; Snehalata A Pawar; Qiang Fu; Prem K Gupta; Maaike Berbée; Sarita Garg; Vijayalakshmi Sridharan; Wenze Wang; Prabath G Biju; Kimberly J Krager; Marjan Boerma; Sanchita P Ghosh; Amrita K Cheema; Howard P Hendrickson; Nukhet Aykin-Burns; Martin Hauer-Jensen
Journal:  Antioxid Redox Signal       Date:  2013-05-03       Impact factor: 8.401

6.  Detection of radiation-induced lung injury using hyperpolarized (13)C magnetic resonance spectroscopy and imaging.

Authors:  K Thind; A Chen; L Friesen-Waldner; A Ouriadov; T J Scholl; M Fox; E Wong; J VanDyk; A Hope; G Santyr
Journal:  Magn Reson Med       Date:  2012-10-16       Impact factor: 4.668

7.  Treg depletion attenuates irradiation-induced pulmonary fibrosis by reducing fibrocyte accumulation, inducing Th17 response, and shifting IFN-γ, IL-12/IL-4, IL-5 balance.

Authors:  Shanshan Xiong; Renfeng Guo; Zhihua Yang; Long Xu; Li Du; Ruoxi Li; Fengjun Xiao; Qianjun Wang; Maoxiang Zhu; Xiujie Pan
Journal:  Immunobiology       Date:  2015-07-17       Impact factor: 3.144

Review 8.  Targeting the TGFβ signalling pathway in disease.

Authors:  Rosemary J Akhurst; Akiko Hata
Journal:  Nat Rev Drug Discov       Date:  2012-09-24       Impact factor: 84.694

Review 9.  The senescence-associated secretory phenotype: the dark side of tumor suppression.

Authors:  Jean-Philippe Coppé; Pierre-Yves Desprez; Ana Krtolica; Judith Campisi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

Review 10.  Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases.

Authors:  Xi-Lin Chen; Charles Kunsch
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

View more
  24 in total

1.  Pituitary adenylate cyclase-activating polypeptide ameliorates radiation-induced cardiac injury.

Authors:  Huan Li; Lu Cao; Pei-Qiang Yi; Cheng Xu; Jun Su; Pei-Zhan Chen; Min Li; Jia-Yi Chen
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

2.  Pilot trial of topical MTS‑01 application to reduce dermatitis in patients receiving chemoradiotherapy for stage I‑III carcinoma of the anal canal.

Authors:  Deborah Citrin; Luca Valle; Kevin Camphausen; Theresa Cooley-Zgela; Deedee Smart; Michael Yao; James B Mitchell; William Thompson; Irini Sereti; Thomas Uldrick
Journal:  Int J Oncol       Date:  2022-04-19       Impact factor: 5.650

3.  Platelet glycoprotein Ibα provides radiation protection.

Authors:  Adam Corken; Sanchita P Ghosh; Ruofei Du; Marjan Boerma; Jerry Ware; Rupak Pathak
Journal:  Radiother Oncol       Date:  2021-12-28       Impact factor: 6.280

Review 4.  Late Sequelae of Radiotherapy—The Effect of Technical and Conceptual Innovations in Radiation Oncology.

Authors:  Ulrike Hoeller; Kerstin Borgmann; Michael Oertel; Uwe Haverkamp; Volker Budach; Hans Theodor Eich
Journal:  Dtsch Arztebl Int       Date:  2021-03-26       Impact factor: 5.594

Review 5.  Vaginal necrosis: A rare late toxicity after radiation therapy.

Authors:  Angela Y Jia; Akila N Viswanathan
Journal:  Gynecol Oncol       Date:  2020-12-07       Impact factor: 5.482

Review 6.  A hypothesis for the pathogenesis of radiation-induced oral mucositis: when biological challenges exceed physiologic protective mechanisms. Implications for pharmacological prevention and treatment.

Authors:  Stephen T Sonis
Journal:  Support Care Cancer       Date:  2021-03-13       Impact factor: 3.603

Review 7.  The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis.

Authors:  Jessica Lawrence; Richard Nho
Journal:  Int J Mol Sci       Date:  2018-03-08       Impact factor: 5.923

8.  Evaluation of a Novel Liquid Fiducial Marker, BioXmark®, for Small Animal Image-Guided Radiotherapy Applications.

Authors:  Kathryn H Brown; Mihaela Ghita; Giuseppe Schettino; Kevin M Prise; Karl T Butterworth
Journal:  Cancers (Basel)       Date:  2020-05-18       Impact factor: 6.639

Review 9.  Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection.

Authors:  Eric M Pietras; Markus G Manz; Francisco Caiado
Journal:  J Exp Med       Date:  2021-06-15       Impact factor: 14.307

Review 10.  Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation.

Authors:  Matthew G K Benesch; Iain T K MacIntyre; Todd P W McMullen; David N Brindley
Journal:  Cancers (Basel)       Date:  2018-03-15       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.